Physician profile
Michael Vanwagner
NPI 1639551559
$4,642.49
in general payments reported to CMS, 2019-2025
16 companies · $549 in 2025
The $549 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,150 · 2020: $94.06 · 2021: $1,286 · 2022: $118 · 2023: $102 · 2024: $344 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,398.38 | 2021-2025 | Persona, Juggerknotless Soft Anchor, Rosa |
| Pinnacle, INC | $1,391.03 | 2019 | |
| Stryker Corporation | $1,107.70 | 2019-2025 | Mako |
| Depuy Synthes Sales INC. | $243.77 | 2019-2021 | |
| Axogen | $138.43 | 2019 | |
| Si-Bone, INC. | $94.06 | 2020 | |
| Smith+Nephew, INC. | $57.93 | 2021 | |
| Ferring Pharmaceuticals INC. | $37.52 | 2023 | Euflexxa |
| Bioventus LLC | $33.24 | 2023 | Gelsyn-3 |
| Pacira Pharmaceuticals Incorporated | $31.43 | 2023 | Zilretta, Iovera, Exparel |
| Nevro Corp. | $27.54 | 2024 | Senza |
| Heron Therapeutics, INC. | $21.72 | 2021 | |
| Biocomposites INC | $20.03 | 2024 | |
| Ebi, LLC | $16.80 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System |
| Kci USA, INC. | $11.66 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vanwagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.